Cite

    Anita Bosak et al.. “Resorcinol-, catechol- and saligenin-based bronchodilating β2-agonists as inhibitors of human cholinesterase activity.” Journal of enzyme inhibition and medicinal chemistry, vol. 32, 2017, pp. 789–797. http://access.bl.uk/ark:/81055/vdc_100046692323.0x000063